Evolus, Inc. - צמיחת מכירות משנה לשנה (TTM) EOLS

Evolus, Inc. (EOLS) generates revenue from a high-demand cosmetic injectable that creates sustainable demand. The rolling annual sales growth metric on GURU.Markets illustrates this revenue trend, where 13.90 is recorded as the baseline value. Ambitious managers operating in a creative environment at the intersection of pharma and beauty drive this growth. The positioning of Jeuveau as an affordable premium product and the digitalization of clinics strengthen the company's market position.
פילוחי נתונים אנליטיים מרוכזים עבור Jeuveau (EOLS)

The metric is calculated as the percentage change in aggregate revenue over the last four quarters relative to the same period last year, which allows for the neutralization of seasonality and the identification of the true dynamics of business expansion. For Evolus, Inc. (EOLS), which implements innovative neurotoxins and digital marketing, the year-over-year sales growth rate over the trailing four quarters serves as an indicator of the effectiveness of its market share capture in aesthetic medicine.